Corrigendum to "Neopetroside-B alleviates doxorubicin-induced cardiotoxicity via mitochondrial protection" [Biomed. Pharmacother. 165 (2023) 115232]

Affiliations

¹ Cardiovascular and Metabolic Disease Center, Smart Marine Therapeutics Center, Department of Physiology, College of Medicine, Inje University, Busan 47397, South Korea.
² Laboratory of Glycoconjugate Chemistry, N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow 119991, Russia.
³ Cardiovascular and Metabolic Disease Center, Smart Marine Therapeutics Center, Department of Physiology, College of Medicine, Inje University, Busan 47397, South Korea. Electronic address: phyhanj@gmail.com.

Free article

Published Erratum

Chang Shin Yoon et al. Biomed Pharmacother. 2023.

Free article

. 2023 Dec 31:169:115933.

doi: 10.1016/j.biopha.2023.115933. Epub 2023 Nov 25.

¹ Cardiovascular and Metabolic Disease Center, Smart Marine Therapeutics Center, Department of Physiology, College of Medicine, Inje University, Busan 47397, South Korea.
² Laboratory of Glycoconjugate Chemistry, N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow 119991, Russia.
³ Cardiovascular and Metabolic Disease Center, Smart Marine Therapeutics Center, Department of Physiology, College of Medicine, Inje University, Busan 47397, South Korea. Electronic address: phyhanj@gmail.com.

No abstract available

Erratum for

Neopetroside-B alleviates doxorubicin-induced cardiotoxicity via mitochondrial protection.
Yoon CS, Nifantiev NE, Yashunsky DV, Kim HK, Han J. Yoon CS, et al. Biomed Pharmacother. 2023 Sep;165:115232. doi: 10.1016/j.biopha.2023.115232. Epub 2023 Jul 29. Biomed Pharmacother. 2023. PMID: 37523986